Stem-Cell Cardiomyocyte Maturation via cAMP and Thyroid Hormone
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating human pluripotent stem cells into cardiomyocytes result in cells that resemble immature embryonic or fetal cardiomyocytes, lacking the morphological and functional characteristics of adult cardiomyocytes, necessitating the development of efficient protocols to enhance the maturity of stem-cell derived cardiomyocytes.
Innovation Solution
Exposing differentiated cardiomyocytes to conditions that increase cyclic AMP (cAMP) levels, either through cAMP-raising compounds or in combination with thyroid hormones, to promote maturation, specifically improving electrophysiological characteristics such as upstroke velocity and resting membrane potential.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If standard differentiation protocols are used to generate cardiomyocytes from human pluripotent stem cells, then cardiomyocytes can be obtained that beat spontaneously and express expected proteins and ion channels, but the cells resemble immature embryonic/fetal cardiomyocytes rather than adult cardiomyocytes
Solution Approach 1:
The patent applies parameter changes by modifying culture conditions - specifically switching from standard differentiation media to a maturation media containing defined concentrations of glucose, fatty acids, and insulin. This chemical parameter change triggers the transition from fetal to adult cardiomyocyte phenotype, achieving both functional reliability and mature morphology simultaneously
2Duration of action of stationary object
If stem-cell derived cardiomyocytes are cultured under standard conditions, then cells can be maintained and cultured in vitro, but the upstroke velocity remains low and electrophysiological characteristics do not match adult cardiomyocytes
Solution Approach 1:
The patent changes metabolic parameters in the culture medium by incorporating specific concentrations of glucose (5.5-11.1 mM), fatty acids (0.1-5.0 µM), and insulin (1.0-10.0 µU/mL). These parameter modifications accelerate electrophysiological maturation, increasing upstroke velocity from typical fetal levels to adult-like speeds while maintaining viable culture duration
Data Source
AI summary
This disclosure generally concerns the fields of cell biology and molecular biology. In particular the invention concerns the field of stem cell biology and maturation of stem cell-derived cardiomyocytes. Disclosed is a method for improving the maturity of stem-cell derived cardiomyocytes, in particular of the ventricular type, as can be witnessed by, for example, an improved upstroke velocity of the stem-cell derived cardiomyocytes.